A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 179 participants.

Also called NCT04663282

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 179 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04663282
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States, Australia, China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04663282. Randomized; no masking; primary purpose treatment. Start 2021-02-04 (actual); primary completion 2022-05-28 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics
Intervention (Drug)
INS068 injection
Intervention (Drug)
Insulin Degludec
Lead sponsor
Jiangsu HengRui Medicine Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04663282
Content hash
987bbd8b40e142adad36bebff7e89730cb9da326edcdc77651912b2e3af29291